A population-based study of plasma cyclic guanosine monophosphate:: relations to age, atrial natriuretic factor and angiotensin-converting enzyme activity

被引:1
|
作者
Nyström, FH
Ahlner, J
Karlberg, BE
Öhman, PK [1 ]
机构
[1] Linkoping Univ Hosp, Fac Hlth Sci, Dept Med & Care, S-58185 Linkoping, Sweden
[2] Linkoping Univ Hosp, Fac Hlth Sci, Dept Clin Pharmacol, S-58185 Linkoping, Sweden
来源
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION | 1998年 / 58卷 / 08期
关键词
blood pressure monitoring; cyclic guanosine monophosphate; atrial natriuretic factor; angiotensin-converting enzyme;
D O I
10.1080/00365519850186021
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In order to study the relations between plasma cyclic guanosine monophosphate (cGMP) and anthropometric variables, plasma atrial natriuretic factor (ANP) and serum angiotensin-converting enzyme activity (ACE), a population study with random selection of 217 subjects (49% men) 18-69 years old was performed. Venous blood was drawn at 08.00 h and ambulatory blood pressure (ABP) recording was then performed. There was no gender-difference in cGMP levels (men 2.2 +/- 1.1 nmol L-1 women 2.2 +/- 1.1 nmol L-1). A weak negative correlation was seen between cGMP and systolic ABP in both genders 20-44 years of age (r= -0.3, p=0.05 for both), but this correlation did not persist in multivariate analysis with correction for ANP, age and ACE. In women, cGMP correlated positively with ANP (r = 0.27, p = 0.005) independently of ANP, ACE, ABP and age. ACE correlated negatively with cGMP in men (all; r = -0.22, p = 0.03, 45 - 69 years of age r= -0.49, p = 0.0002) and this correlation was independent of ANP, ACE, ABP and age. ACE catalyses the breakdown of bradykinin, which stimulates the release of NO. As the second messenger of NO is cGMP, the negative correlation between ACE and cGMP in men might be a reflection of reduced production of NO. Our results also suggest that there are gender differences in the stimuli for basal cGMP production.
引用
收藏
页码:605 / 610
页数:6
相关论文
共 50 条
  • [31] Insertion/deletion polymorphism of the angiotensin-converting enzyme gene influences circadian pulse rate variability in the population-based family study
    Czarnecka, D
    Stolarz, K
    Olszanecka, A
    Kiec-Wilk, B
    Dembinska-Kiec, A
    Kawecka-Jaszcz, K
    JOURNAL OF HYPERTENSION, 2004, 22 : S345 - S345
  • [32] Insertion/deletion polymorphism of the angiotensin-converting enzyme gene influences circadian pulse rate variability in the population-based family study
    Czarnecka, D
    Stolarz, K
    Olszanecka, A
    Styczkiewicz, M
    Kiec-Wilk, B
    Dembinska-Kiec, A
    Kawecka-Jaszcz, K
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 80A - 80A
  • [33] RELATIONS BETWEEN MYOCARDIAL-CONTRACTILITY, MYOSIN PHENOTYPE, AND PLASMA ANGIOTENSIN-CONVERTING ENZYME-ACTIVITY IN THE CARDIOMYOPATHIC HAMSTER
    LAMBERT, F
    LECARPENTIER, Y
    LOMPRE, AM
    SCALBERT, E
    DESCHE, P
    CHEMLA, D
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (03) : 410 - 415
  • [34] A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors
    Cressman, Alex M.
    Macdonald, Erin M.
    Fernandes, Kimberly A.
    Gomes, Tara
    Paterson, J. Michael
    Mamdani, Muhammad M.
    Juurlink, David N.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (04) : 662 - 669
  • [35] Patterns of Angiotensin Converting Enzyme Inhibitor Prescriptions for Different Indications: A Population-based Study
    Mahmoudpour, Seyed Hamidreza
    Asselbergs, Folkert W.
    Souverein, Patrick C.
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 202 - 203
  • [36] ROLE OF ATRIAL-NATRIURETIC-FACTOR, ANGIOTENSIN-CONVERTING ENZYME AND ANGIOTENSIN-II RECEPTOR GENES IN HYPERTENSION AND CARDIAC-HYPERTROPHY OF SPONTANEOUSLY HYPERTENSIVE RATS
    ZHANG, L
    WEST, MJ
    SUMMERS, KM
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 1476 - 1476
  • [37] Interaction effects between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and steroid or antiviral therapies in COVID-19: A population-based study
    Zhou, Jiandong
    Tse, Gary
    Lee, Sharen
    Liu, Tong
    Cao, Zhidong
    Zeng, Daniel Dajun
    Leung, Keith Sai Kit
    Wai, Abraham Ka Chung
    Wong, Ian Chi Kei
    Cheung, Bernard Man Yung
    Zhang, Qingpeng
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (05) : 2635 - 2641
  • [38] Intolerance to Angiotensin Converting Enzyme Inhibitors in Asthma and the General Population: A UK Population-Based Cohort Study
    Morales, Daniel R.
    Lipworth, Brian J.
    Donnan, Peter T.
    Wang, Huan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (09): : 3431 - +
  • [39] PRESENCE OF ATRIAL-NATRIURETIC-FACTOR AND CYCLIC GUANOSINE-MONOPHOSPHATE IN SALIVA - COMPARISON OF PLASMA AND SALIVARY CONCENTRATIONS DURING A HEAD-DOWN TILT
    GAUQUELIN, G
    MAILLET, A
    ALLEVARD, AM
    VOROBIEV, D
    GRIGORIEV, AI
    GHARIB, C
    EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY, 1992, 65 (01): : 25 - 29
  • [40] Risk of Viral Infection in Patients Using Either Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers: A Nationwide Population-based Propensity Score Matching Study
    Lin, Shih-Yi
    Ju, Shu-Woei
    Lin, Cheng-Li
    Lin, Cheng-Chieh
    Hsu, Wu-Huei
    Chou, Chia-Hui
    Chi, Chih-Yu
    Hsu, Chung-Y
    Kao, Chia-Hung
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (10) : 2695 - 2701